Tumor markers in the monitoring of ovarian cancer
Xu, S.X.
Zhonghua Fu Chan Ke Za Zhi 25(6): 345-347; 383
1990
ISSN/ISBN: 0529-567X PMID: 2282861 Document Number: 367338
This study was carried out to determine the serum level of Ca125, LSA (lipid associated sialic acid) and AGP (alpha acid glycoprotein) in 50 patients with ovarian tumors. Among 30 patients with ovarian cancer, 12 reacted to all three markers, 22 reacted to two markers and 27 reacted to one marker. The sensitivities of LSA and CA125 were 60% and 77%, respectively and the specificities were 85% and 90%. A sensitivity of 87% and a specificity of 95%, when the two markers were used in combination.
Document emailed within 1 workday
Related Documents
Nozawa, S.; Udagawa, Y.; Sasaki, H.; Ito, K.; Akiya, K.; Terashima, Y.; Takamizawa, H.; Ohkura, H.; Fujimoto, S.; Hashimoto, M. 1992: Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 2085-2093Schuurman, J.J.; Bong, S.B.; Einarsson, R. 1996: Determination of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients Anticancer Research 16(4b): 2169-2172
Hou, J.-X.; Yang, X.-Q.; Chen, C.; Jiang, Q.; Yang, G.-L.; Li, Y. 2011: Screening the gastric cancer related tumor markers from multi-tumor markers protein chip with kappa coefficient and cost-effectiveness analysis Hepato-Gastroenterology 58(106): 632-636
Fioretti, P.; Gadducci, A.; Ferdeghini, M.; Bartolini, T.; Scatena, P.; Facchini, V.; Bianchi, R. 1986: Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancer European Journal of Gynaecological Oncology 7(3): 200-205
Zhyl'chuk, V.I.; Alistratov, O.V.; Vorontsova, A.L. 1998: The evaluation of the efficacy of adjuvant laferon therapy in the combined treatment of patients with ovarian cancer based on the monitoring of the tumor marker Ca-125 in the blood serum Likars'ka Sprava 2: 137-139
Sevelda, P.; Dittrich, C.; Salzer, H.; Pateisky, N.; Spona, J. 1986: Monitoring the cytotoxic potential of a sequential polychemotherapy (adriamycin/cisplatin-vincristine/cyclophosphamide-high dose methotrexate) in patients with advanced ovarian cancer with the tumor marker CA-125 Cancer Detection and Prevention 9(5-6): 521-528
Margariti, P.A.; Benedetti Panici, P.; Villani, L.; Di Roberto, P.; Maiorca, A.; Sacco, F.; Bompiani, A. 1980: Tumor markers in the ovarian carcinoma European Journal of Gynaecological Oncology 1(2): 77-79
Ławicki, S.ła.; Mroczko, B.; Szmitkowski, M. 2002: Tumor markers useful for diagnosis and monitoring of lung neoplasm Postepy Higieny i Medycyny Doswiadczalnej 56(1): 93-118
Zielińiska, K.; Karczmarek-Borowska, B. 2013: Usefulness of the chosen tumor markers at diagnostics and monitoring the treatment Przeglad Lekarski 70(11): 986-990
Mahler, B. 2008: Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma Pneumologia 57(3): 175-177
Morelli, M.; Nardi, M.; Valle, M.; Balducci, D.; Serafini, D.; Bernardini, P. 1985: Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms Minerva Medica 76(34-35): 1529-1531
Gramellini, D.; Rutolo, S.; Verrotti, C.; Piantelli, G.; Fieni, S.; Vadora, E. 2001: Sonographic characterization, Doppler ultrasonography and tumor markers in the diagnosis of malignancy of ovarian masses Minerva Ginecologica 53(1): 1-11
Kiricuta, I.; Bojan, O.; Munteanu, S. 1986: Biochemical markers in ovarian cancer Archiv für Geschwulstforschung 56(1): 35-38
Gargano, G.; Correale, M.; Abbate, I.; Falco, G.; De Frenza, N.; Lorusso, V.; De Lena, M.; De Leonardis, A. 1990: The role of tumour markers in ovarian cancer Clinical and Experimental Obstetrics and Gynecology 17(1): 23-29
Sparholt, M.H.; Høgdall, E.; Høgdall, C.K. 2009: Tumour markers in epithelial ovarian cancer Ugeskrift for Laeger 171(48): 3505-3509
Virji, M.A.; Mercer, D.W.; Herberman, R.B. 1989: New immunologic markers for monitoring of cancer Annales Chirurgiae et Gynaecologiae 78(1): 13-26
Vinokurov, V.L.; Dudarev, A.L.; Jurkova, L.E.; Lapchenkov, V.I.; Barbanel, E.J. 1992: Tumor marker CA 125 in diagnosis, monitoring management and follow-up of patients with ovarian tumors European Journal of Gynaecological Oncology 13(2): 205-208
Li, L.; Yang, Z.J.; Wang, Q. 2017: Current status and future of epithelial ovarian cancer markers Zhonghua Fu Chan Ke Za Zhi 52(1): 4-7
Yamauchi, M.; Yoshigoe, F.; Mera, F.; Ogura, K.; Kameda, H.; Nakada, J.; Takasaka, S.; Machida, T.; Fukunaga, M. 1983: An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers Gan no Rinsho. Japan Journal of Cancer Clinics 29(4): a
Yin, D.; Zhang, X.; Feng, Y. 1996: Effects of recombinant human tumor necrosis factor on the development of ascitic tumor and expression of c-erbB2 in the nude mouse models of ovarian cancer Zhonghua Fu Chan Ke Za Zhi 31(5): 291-292